Literature DB >> 22032996

Osteoporotic hip fracture costs in the elderly Turkish population.

Simin Hepgüler1, Alp Cetin, Cetin Değer, Ulkem Erkent.   

Abstract

OBJECTIVE: This study was designed to determine the length of hospital stay and treatment costs of patients with osteoporotic hip fractures in Turkey.
METHODS: A total of 1,118 osteoporotic hip fractures taken from patient records in 35 hospitals connected to a Disease Related Group (DRG) network were included in the study. Inclusion criteria were patients over the age of fifty with a diagnosis of a single, low-energy fracture located at the neck, head, or intertrochanteric region of the femur treated with total/hemi-arthroplasty, screw or nail methods. We examined the demographics, location of fracture, treatment type, length of hospital stay (LOS), direct cost and cost extrapolation based on the numbers of hospitals, beds and patient by hospital.
RESULTS: Of the 1,118 patients (mean age: 75.3 ± 9.9 years), 62.8% were female. The main fracture type was of the femur neck without precise localization. The average LOS was 11.0 ± 7.9 days. The total weighed cost of all 1,118 hip fractures was $2,249,885 per year, indicating an average direct medical cost of $3,119 per patient in the 35 DRG hospitals. Based on this sample, the estimated total number of patients is 15,602 by number of hospitals; 8,521 by number of hospital beds and 9,365 by number of hospitalization, costing $31,530 million; $14,793 million and $18,948 million, respectively.
CONCLUSION: Diverse results in cost estimations of osteoporotic hip fractures reflect the incoherence of data as well as a lack of standardization of health care services. Therefore, ICD and DRG coding needs to be improved and a national database must be created at least for the invoices of importation of prostheses to fully be able to calculate the burden of osteoporosis across Turkey.

Entities:  

Mesh:

Year:  2011        PMID: 22032996     DOI: 10.3944/AOTT.2011.2543

Source DB:  PubMed          Journal:  Acta Orthop Traumatol Turc        ISSN: 1017-995X            Impact factor:   1.511


  7 in total

Review 1.  Economic burden of osteoporosis-related hip fracture in Asia: a systematic review.

Authors:  N-A Mohd-Tahir; S-C Li
Journal:  Osteoporos Int       Date:  2017-03-17       Impact factor: 4.507

2.  Comparative Interrupted Time Series Analysis of Long-term Direct Medical Costs in Patients With Hip Fractures and a Matched Cohort: A Large-database Study.

Authors:  Suk-Yong Jang; Jang-Won Lee; Kap-Jung Kim; Ha-Yong Kim; Won-Sik Choy; Yonghan Cha
Journal:  Clin Orthop Relat Res       Date:  2021-11-22       Impact factor: 4.176

3.  Mean Platelet Volume to Platelet Count Ratio as a Predictor of Mortality in Unstable Pertrochanteric Fracture Treated with Short Proximal Femoral Anterograde Nail.

Authors:  Orhan Balta; Harun Altınayak; Kürşad Aytekin; Mehtap Gürler Balta; Osman Demir; Eyüp Çağatay Zengin
Journal:  Indian J Orthop       Date:  2022-02-24       Impact factor: 1.033

4.  Risk factors for acute kidney injury after hip fracture surgery in the elderly individuals.

Authors:  Cagatay Ulucay; Zehra Eren; Elif Cigdem Kaspar; Turhan Ozler; Korcan Yuksel; Gulcin Kantarci; Faik Altintas
Journal:  Geriatr Orthop Surg Rehabil       Date:  2012-12

5.  The Cost and Consequences of Failed Osteosynthesis of Intertrochanteric Femur Fractures: A Matched Cohort Study.

Authors:  Erdi Özdemir; Mustafa Caner Okkaoglu; Ali Teoman Evren; Yuksel Ugur Yaradilmis; Ahmet Ates; Murat Altay
Journal:  Indian J Orthop       Date:  2021-01-03       Impact factor: 1.251

Review 6.  Economic burden of osteoporosis in the world: A systematic review.

Authors:  Asma Rashki Kemmak; Aziz Rezapour; Reza Jahangiri; Shima Nikjoo; Hiro Farabi; Samira Soleimanpour
Journal:  Med J Islam Repub Iran       Date:  2020-11-12

7.  Diabetes and risk of fracture-related hospitalization: the Atherosclerosis Risk in Communities Study.

Authors:  Andrea L C Schneider; Emma K Williams; Frederick L Brancati; Saul Blecker; Josef Coresh; Elizabeth Selvin
Journal:  Diabetes Care       Date:  2012-12-17       Impact factor: 19.112

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.